Working at Roswell Park Comprehensive Cancer Center will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers, to contribute to the history of the nation’s first cancer center, to broaden your career experiences, and to be part of a team that contributes to easing the experiences of our patients and their families. Ready to learn more about a great new career opportunity? Read more here: Nurse II - Lymphoma & Multiple Myeloma Clinic https://bit.ly/4cvgysC
Roswell Park Comprehensive Cancer Center’s Post
More Relevant Posts
-
World LYMPHOMA Awareness Day . 15/Sep/2023 . Follow us for more @drjyotioncocare . . 🩺Dr.Jyoti Anand ✍MBBS, DNB Internal Medicine, DNB Medical Oncology . . 👉Book online Consultation +91 7042088787 . . . #drjyotianand #drjyotioncocare #jyotioncocare #WorldLymphomaDay #LymphomaAwareness #KnowLymphoma #FightLymphoma #LymphomaWarrior #BeatLymphoma #LymphomaSupport #LymphomaSurvivor #HopeForLymphoma #BloodCancerAwareness #LymphomaResearch #CancerAwareness #FindACure #RaiseAwareness #supportcancerpatients
To view or add a comment, sign in
-
-
Breakthrough in Pediatric Lymphoma Detection! Challenge: Accurately tracking subtle changes in PET scans for pediatric Hodgkin lymphoma patients during treatment is difficult. Solution: Xin Tie et al. (2023) developed LAS-Net, an innovative AI network that analyzes both baseline and follow-up PET scans to detect residual disease more effectively. Results: Outperforms traditional methods in detecting residual lymphoma. Strong correlation with physician measurements of key PET metrics like MTV and TLG. This paves the way for more precise treatment decisions and improved patient outcomes! Researchers: Interested in learning more about LAS-Net? Let's connect and discuss its potential applications in your work! Patients and Families: Have questions about PET scans and pediatric Hodgkin lymphoma? Share your thoughts in the comments below! #ArtificialIntelligence #PediatricCancer #Lymphoma #MedicalImaging #Innovation https://lnkd.in/g2aaaA2i
arxiv.org
To view or add a comment, sign in
-
New study reveals how gender affects liver transplant success in cancer patients
New study reveals how gender affects liver transplant success in cancer
To view or add a comment, sign in
-
Lymphoma is a curable Blood Cancer What you require is to undergo proper diagnosis and plan of management Sharing my views for basic understanding of this disease #lymphoma #bloodcancer #cancerawareness #cancertreatment #hematology
Lymphoma/Blood Cancer/ Curable Disease/हिंदी में
https://www.youtube.com/
To view or add a comment, sign in
-
This week's favorite Directory image was submitted by Jayalakshmi Panicker Balakrishna, M.D. Diagnosis: PDL1 expression in T cell / histiocyte rich large B-cell lymphoma. OCT2-PDL1 dual IHC stain, x400 Dr. Balakrishna's Directory entry: https://lnkd.in/dKwBA_pt Visit https://lnkd.in/erRH2tq to create your own profile and add a favorite image. #directory #pathology #pathologyoutlines #hematopathology
To view or add a comment, sign in
-
-
Join Wakely and the The Leukemia & Lymphoma Society for an informational webinar on November 29, 2023, from 1:00 – 2:00 PM ET. We will highlight the key findings in a recent Wakely study, sponsored by the Leukemia & Lymphoma Society, which revealed significant cost disparities in medical services based on where they are performed. The analysis suggested that equalizing payment rates for certain outpatient services across different settings could result in substantial savings for beneficiaries, particularly those with higher medical needs. Register here 👇 https://lnkd.in/gPdyT6bg Featured Speakers: Rachel Stewart, Julie Steiner, Darren Johnson #webinar #siteneutralpaymentreform #siteneutral #siteneutralpolicy #paymentreform #Medicare #MedicareAdvantage #commercial #beneficiarycost #OOPC #costsavings #savings
Welcome! You are invited to join a webinar: Site Neutral Payment Reform Has the Potential to Significantly Reduce Out-of-Pocket Patient Spend. After registering, you will receive a confirmation email about joining the webinar.
healthmanagement.zoom.us
To view or add a comment, sign in
-
🌐💻 Revolutionizing cancer care: Introducing our eHealth tool for monitoring immune-related adverse events (irAEs)! 🌟👩⚕️ Managing immune-related adverse events in cancer treatment demands precision and timely intervention. Our eHealth tool addresses this challenge by providing a comprehensive platform to monitor, document, and analyze irAEs, ensuring a more nuanced approach to patient care. Immunotherapy is rapidly advancing and can now be considered a powerful new tool in the treatment of cancer. It is associated with unique irAEs that are more unpredictable than chemotherapy adverse events (AEs), early detection and relevant treatment initiation can manage most of these side effects. Watch our video @ https://lnkd.in/gpPaF5Ag and explore the role of eHealth tools in the future of personalized medicine. #eHealthInnovation #CancerCareRevolution #PersonalizedMedicine #TechInHealthcare #LungCancer #PersonalizedMedicine #LungCancerCare #InnovationsInMedicine #Chemotherapy #Immunotherapy #LungCancerManagement #LungCancerCauses #CellTalk #LifeScience #Oncology #Immunology #Neurology #ScientificCollaborations #ClinicalTrails #Research
Development of an eHealth tool for capturing and analyzing the irAEs in cancer treatment | CellTalk
https://www.youtube.com/
To view or add a comment, sign in
-
Dear Colleagues, A recent publication in the American Journal of Case Reports by authors from Mishuku Hospital, Tokyo, Japan, describes the diagnostic challenges of intravascular large B-cell lymphoma (IVLBCL). The article highlights the utility of contrast-enhanced ultrasonography (CEUS) in distinguishing IVLBCL from mass-forming lymphoma involving the liver. By evaluating the absence of a defect in the post-vascular phase, CEUS can help clinicians select appropriate lesions for biopsy. This practical insight offers valuable guidance in diagnosing IVLBCL, a rare and elusive condition. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/dSMjqJhd
To view or add a comment, sign in
-
Dear Colleagues, A recent publication in the American Journal of Case Reports by authors from Mishuku Hospital, Tokyo, Japan, describes the diagnostic challenges of intravascular large B-cell lymphoma (IVLBCL). The article highlights the utility of contrast-enhanced ultrasonography (CEUS) in distinguishing IVLBCL from mass-forming lymphoma involving the liver. By evaluating the absence of a defect in the post-vascular phase, CEUS can help clinicians select appropriate lesions for biopsy. This practical insight offers valuable guidance in diagnosing IVLBCL, a rare and elusive condition. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/dTG6kqPa
To view or add a comment, sign in